Table 1 The clinicopathological characteristics of 170 patients with gastric cancer
Number (N) | Percentage (%) | |
|---|---|---|
Gender | ||
Male | 97 | 57.06 |
Female | 73 | 42.94 |
Age | ||
≤50 years | 34 | 20.00 |
>50 years | 136 | 80.00 |
Tumor Location | ||
Proximal | 79 | 46.47 |
Distal | 91 | 53.53 |
Tumor Size (cm) | ||
≤5 | 115 | 67.65 |
>5 | 55 | 32.35 |
Lauren Classification | ||
Intestinal | 73 | 42.94 |
Diffuse | 97 | 57.06 |
Tumor Stage | ||
Early | 90 | 52.94 |
Advanced | 80 | 47.06 |
LN Metastasis | ||
No | 74 | 43.53 |
Yes | 96 | 56.47 |
Endpoint Status | ||
Survival | 95 | 55.88 |
Death | 75 | 44.12 |
OPN Staining | ||
≤50% | 79 | 46.47 |
>50% | 91 | 53.53 |
CD204 Staining | ||
≤50% | 79 | 46.47 |
>50% | 91 | 53.53 |